Dimension Vista Flex Reagent Cartridges
Colorimetry, Acetaminophen. 510(k) K061655, from Dade Behring, Inc. (Newark, DE). Product code LDP, class 2.
As of Nov 18, 2026, K061655 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Jul 10, 2006 after 27 days, with 7 recalls tied to it in FDA's recall database.
- Substantially equivalent: Jul 10, 2006
- Review time: 27 days
- Recalls: 7
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Dimension Vista™ Acetaminophen (ACTM) Flex® reagent cartridge is a device intended to measure acetaminophen, an analgesic and antipyretic (fever reducing) drug, in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of acetaminophen overdose.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Acetaminophen Flex Reagent CartridgeK963244 · Dade Intl., Inc. · Sep 23, 1996
- Dimension Lidocaine (Lido) Flex Reagent Cartridge Method, Dimension Drug Calibrator Ii, Models DF113. DC49DK033809 · Dade Behring, Inc. · Feb 20, 2004
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- Dimension Vista Chemistry 1 Calibrator (CHEM 1 CAL), Dimension Vista Magnesium Flex reagent cartridge (MG)K140790 · Siemens Healthcare Diagnostics · Jun 15, 2015
Recalls
Recalls FDA ties to K061655, newest first; each opens FDA's recall record| Jun 29, 2017 | Z-1660-2018Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results. | Terminated |
| Jun 29, 2017 | Z-1658-2018Various assays used to measure different chemical levels in blood, urine, or cerebrospinal fluid may interfere with the drugs sulfasalazine and/or sulfapyridine causing falsely elevated or falsely depressed results. | Terminated |
| Mar 17, 2016 | Z-1665-2016Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may… | Terminated |
| Mar 17, 2016 | Z-1666-2016Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may… | Terminated |
| Sep 30, 2015 | Z-0339-2016Erroneous low results on a small number of reagent wells. There is the potential for under-recovery on certain wells for quality control (QC) and patient sample results. The under-recovery ranged from -0.3 mg/dL [0.12… | Terminated |
| Jul 17, 2012 | Z-2175-2012Siemens has received complaints of customers experiencing slopes >1.05 when calibrating Flex(R) reagent cartridge lot 12095AD. This results in a slope failure and prevents the VANC assay from being run on the Dimension… | Terminated |
| Feb 17, 2012 | Z-1433-2012Firm has confirmed a negative shift of approximately 0.2mg/dL [0.08 mmol/L] in patient and QC samples when using Vista Magnesium | Terminated |
Other LDP Clearances
The newest 510(k)s for the same product code; see every LDP device- Atellica CH Acetaminophen 2 (ACTM)K261364 · Siemens Healthcare Diagnostics, Inc. · Jul 24, 2026
- AcetaminophenK202644 · Sekisui Diagnostics P.E.I., Inc. · Feb 18, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Jun 13, 2006
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3030
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files